Patient‐identified most bothersome symptom in preventive migraine treatment with eptinezumab: A novel patient‐centered outcome

por Lipton, Richard B., Dodick, David W., Ailani, Jessica, McGill, Lora, Hirman, Joe, Cady, Roger
Publicado 2021

Likelihood of response with subsequent dosing for patients with migraine and initial suboptimal response with eptinezumab: A post hoc analysis of two placebo‐controlled randomized...

por Schim, Jack D., Anderson, Carlton, Brunner, Elizabeth, Hirman, Joe, Ogbru, Annette, Cady, Roger, McGill, Lora
Publicado 2022